Benign neoplasm of rectum

Summary

Benign neoplasm of rectum (MONDO:0021462) is a cancer. A subtype of rectal neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	benign neoplasm of rectum
Mondo ID	MONDO:0021462
ICD-10-CM	D12.8
ICD-11	1805730142
NCIT	C4774
SNOMED CT	92318000
UMLS	C0496867
MedGen	99222
Anatomy (UBERON)	UBERON:0001052
Is cancer (heuristic)	yes

Also known as: benign neoplasm of the rectum · benign rectal neoplasm · benign rectal neoplasms · benign rectal tumor · benign rectal tumors · benign rectal tumour · benign rectal tumours · benign tumor of rectum · benign tumor of the rectum · benign tumour of rectum · benign tumour of the rectum · rectal neoplasms, benign · rectal tumors, benign · rectum benign neoplasm

Disease family

This is a subtype of rectal neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › large intestine disorder › rectal disorder › rectal neoplasm › benign neoplasm of rectum

Related subtypes (3): anus neoplasm, rectal cancer, epithelial neoplasm of rectum

Subtypes (4): lipoma of the rectum, rectum leiomyoma, benign neoplasm of anus, diffuse cavernous hemangioma of the rectum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.